FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells

Abstract Background Whether there is a mechanistic link between FOLR1 and response to cisplatin has not been extensively examined. In this study, we determine the expression of FOLR1 in ovarian cancer and examine if FOLR1 levels influence response to cisplatin. Results (1) FOLR1 protein expression w...

Full description

Bibliographic Details
Main Authors: Ming-ju Huang, Wei Zhang, Qi Wang, Zhi-jun Yang, Sheng-bin Liao, Li Li
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Journal of Ovarian Research
Subjects:
Folate binding protein
Ovarian cancer
SKOV3 cells
Cisplatin
Apoptosis
Cell cycle
Online Access:http://link.springer.com/article/10.1186/s13048-018-0387-y

Internet

http://link.springer.com/article/10.1186/s13048-018-0387-y

Similar Items